Inspire Investing
RPRX icon

Inspire Investing’s Royalty Pharma RPRX Stock Holding History

Inspire Investing’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.17M Sell
37,171
-42,609
-53% -$2.51M 0.09% 283
2026
Q2 		$4.47M Buy
79,780
+46,034
+136% +$2.4M 0.18% 112
2026
Q1 		$1.62M Sell
33,746
-7,424
-18% -$325K 0.09% 261
2025
Q4 		$1.59M Buy
41,170
+2,618
+7% +$100K 0.14% 162
2025
Q3 		$1.36M Buy
38,552
+6,195
+19% +$224K 0.13% 175
2025
Q2 		$1.17M Buy
32,357
+22,436
+226% +$743K 0.13% 181
2025
Q1 		$309K Sell
9,921
-241
-2% -$7.64K 0.04% 781
2024
Q4 		$259K Buy
10,162
+91
+0.9% +$2.41K 0.03% 777
2024
Q3 		$285K Buy
10,071
+85
+0.9% +$2.35K 0.03% 795
2024
Q2 		$263K Sell
9,986
-33,538
-77% -$930K 0.03% 777
2024
Q1 		$1.32M Buy
43,524
+27,701
+175% +$817K 0.14% 180
2023
Q4 		$444K Buy
15,823
+2,410
+18% +$66.2K 0.05% 329
2023
Q3 		$364K Buy
+13,413
New +$398K 0.05% 344
2023
Q2 		– Sell
-14,699
Closed -$530K – 825
2023
Q1 		$530K Buy
+14,699
New +$545K 0.07% 224

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Achmea Investment Management
Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Inspire Investing's RPRX Position: Q3 2026 in Review

Inspire Investing reduced its Royalty Pharma (RPRX) stake by 53% in Q3 2026, selling an estimated $2.51M and leaving 37,171 shares worth $2.17M. The position accounts for 0.09% of the portfolio, ranked #283.

Inspire Investing first reported a position in RPRX in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.47M in Q2 2026. 275 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Inspire Investing held 37,171 shares of Royalty Pharma worth $2.17M as of Q3 2026.
  • Inspire Investing sold 42,609 Royalty Pharma shares in Q3 2026, an estimated $2.51M.
  • Royalty Pharma made up 0.09% of Inspire Investing's portfolio in Q3 2026, its #283 holding.
  • Inspire Investing first reported a position in Royalty Pharma in Q1 2023 and has held it in 14 quarters since.
  • Inspire Investing's Royalty Pharma position peaked at $4.47M in Q2 2026.
  • 275 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.